Sector portfolio · VC firm · United States

Canaan's Biotech portfolio

Canaan has backed 52 Biotech startups in rounds we track, $4.7B between them, shown by the stage each has reached. The best-funded is Ideaya Biosciences.

52startups backed
4stages
$4.7Braised between them
Series C and laterbiggest stage

Canaan's whole portfolioCanaan's profile

Series C and later

14

Series B

13

Series A

13

Stage not reported

12

Segment by segment

Series C and later

14 startups · $1.3B raised

  1. Unchained LabsUnchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it.United States$193M
  2. ReVision OpticsReVision Optics offers PRESBYLENS, a refractive surgery solution to correct vision loss by the natural aging process.United States$172M
  3. DDermiraDermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.United States$169M
  4. Civitas TherapeuticsCivitas develops pulmonary delivery therapies.United States$122M
  5. AgomAB TherapeuticsAgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.Belgium$112M
  6. SynthekineSynthekine is a biotechnology company based in Menlo Park, California, founded in 2018.United States$100M
  7. Genome MedicalGenome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.United States$98M
  8. Protagonist TherapeuticsProtagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discoveriAustralia$89M

Series B

13 startups · $1.1B raised

  1. Greywolf TherapeuticsGreywolf Therapeutics is a clinical-stage biotechnology company based in Oxford, United Kingdom.United Kingdom$144M
  2. HTHalda TherapeuticsHalda Therapeutics is a research-stage drug discovery company.United States$126M
  3. Arrakis TherapeuticsArrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.United States$113M
  4. Nocion TherapeuticsNocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.United States$112M
  5. TTiaUnited States$103M
  6. IIdeayaUnited States$94M
  7. CTChrono TherapeuticsChrono Therapeutics was founded by Guy DiPierro to cause a paradigm shift in the way addictions and diseases are treated.United States$83M
  8. NormunityNormunity is a biotechnology company founded in 2020, focused on developing innovative precision immuno-oncology therapies.United States$75M

Series A

13 startups · $434M raised

  1. VTVima TherapeuticsUnited States$100M
  2. Envisia TherapeuticsEnvisia Therapeutics is a biotechnology company based in Research Triangle Park, North Carolina, established in 2013 by Liquidia TUnited States$46M
  3. Vedana TherapeuticsVedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.United States$46M
  4. LBLabrys BiologicsLabrys Biologics develops treatments for chronic migraine.-$46M
  5. RallybioRallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.United States$44M
  6. Alphina TherapeuticsAlphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients.United States$40M
  7. CTComet TherapeuticsComet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.United States$29M
  8. DauntlessDauntless is a Seattle-area software developer providing point-of-sale and tracking software to the cannabis industry.United States$25M

Stage not reported

12 startups · $1.8B raised

  1. IDEAYA BiosciencesIDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.United States$608M
  2. Tyra BiosciencesTyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.United States$600M
  3. EndoGastric SolutionsEndoGastric Solutions is a medical device company based in Redmond, Washington.United States$293M
  4. ArvinasArvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.United States$111M
  5. Semnur PharmaceuticalsSemnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.United States$106M
  6. EEndoGastricUnited States$31M
  7. CSCyrano SciencesCyrano Sciences, is focused on providing chemical and biological sensors and software solutions.United States$23M
  8. Transposon TherapeuticsTransposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.United States$22M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Canaan as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioCanaan's Fintech portfolio18 startups · $851MSector portfolioCanaan's AI portfolio17 startups · $2.2BSector portfolioCanaan's Internet portfolio14 startups · $535MSector portfolioCanaan's IT Services portfolio13 startups · $434MCo-investorsWho invests with Canaan234 co-investorsPortfolio mapCanaan portfolio map164 startups · $14B

Raising from investors like Canaan?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps